Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.47B.
ENTERPRISE VALUE (EV)
$3.47B
IDEAYA Biosciences, Inc.
Market Cap
$3.56B
Enterprise Value (EV)
$3.47B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | $3.56B | $3.47B |
| Celcuity Inc. (CELC)vs › | $3.55B | $4.12B |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | $4.00B |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | $3.13B |
| CareDx, Inc (CDNA)vs › | $3.41B | $3.06B |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | $3.31B |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.38B | $2.34B |
| ICU Medical, Inc. (ICUI)vs › | $3.98B | $4.95B |
| Denali Therapeutics Inc. (DNLI)vs › | $3.12B | $2.94B |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.10B | $3.06B |
Market Cap
$3.56B
Total Debt
$27.91M
Cash
$112.83M
Enterprise Value
$3.47B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
